Age of asthma onset does not impact the response to omalizumab

por Rogers, Linda, Holweg, Cecile TJ, Pazwash, Hooman, Ko, Jinnie, Louie, Samuel
Publicado 2023

Overlap of allergic, eosinophilic and type 2 inflammatory subtypes in moderate‐to‐severe asthma

por Chen, Meng, Shepard, Kirk, Yang, Ming, Raut, Pranil, Pazwash, Hooman, Holweg, Cecile T.J., Choo, Eugene
Publicado 2021

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

por Hanania, Nicola A, Noonan, Michael, Corren, Jonathan, Korenblat, Phillip, Zheng, Yanan, Fischer, Saloumeh K, Cheu, Melissa, Putnam, Wendy S, Murray, Elaine, Scheerens, Heleen, Holweg, Cecile TJ, Maciuca, Romeo, Gray, Sarah, Doyle, Ramona, McClintock, Dana, Olsson, Julie, Matthews, John G, Yen, Karl
Publicado 2015

Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics

por Dennis, Glynn, Holweg, Cécile TJ, Kummerfeld, Sarah K, Choy, David F, Setiadi, A Francesca, Hackney, Jason A, Haverty, Peter M, Gilbert, Houston, Lin, Wei Yu, Diehl, Lauri, Fischer, S, Song, An, Musselman, David, Klearman, Micki, Gabay, Cem, Kavanaugh, Arthur, Endres, Judith, Fox, David A, Martin, Flavius, Townsend, Michael J
Publicado 2014

A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER)

por Austin, Cary D., Gonzalez Edick, Melissa, Ferrando, Ronald E., Solon, Margaret, Baca, Miriam, Mesh, Kathryn, Bradding, Peter, Gauvreau, Gail M., Sumino, Kaharu, FitzGerald, J. Mark, Israel, Elliot, Bjermer, Lief, Bourdin, Arnaud, Arron, Joseph R., Choy, David F., Olsson, Julie K., Abreu, Francis, Howard, Monet, Wong, Kit, Cai, Fang, Peng, Kun, Putnam, Wendy S., Holweg, Cécile T.J., Matthews, John G., Kraft, Monica, Woodruff, Prescott G.
Publicado 2020